Non-Current Assets
Accumulated Depreciation
Amgen Accumulated Depreciation decreased by 16.2% to $9.30B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.3%, from $10.60B to $9.30B. Over 5 years (FY 2020 to FY 2025), Accumulated Depreciation shows an upward trend with a 4.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2015
Last reportedQ1 2026Apr 30, 2026
Parent metricPP&E (Net)
Metric ID:
ppe_accumulated_depreciationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.10B | $9.20B | $8.80B | $8.90B | $9.00B | $9.20B | $9.30B | $9.40B | $9.50B | $9.70B | $9.80B | $9.90B | $10.10B | $10.30B | $10.40B | $10.60B | $10.80B | $11.00B | $11.10B | $9.30B |
| QoQ Change | — | +1.1% | -4.3% | +1.1% | +1.1% | +2.2% | +1.1% | +1.1% | +1.1% | +2.1% | +1.0% | +1.0% | +2.0% | +2.0% | +1.0% | +1.9% | +1.9% | +1.9% | +0.9% | -16.2% |
| YoY Change | — | — | — | — | -1.1% | +0.0% | +5.7% | +5.6% | +5.6% | +5.4% | +5.4% | +5.3% | +6.3% | +6.2% | +6.1% | +7.1% | +6.9% | +6.8% | +6.7% | -12.3% |
| % of PP&E (Net) | 185.5% | 184.7% | 169.8% | 173.1% | 174.5% | 177.3% | 171.4% | 172.2% | 171.7% | 174.4% | 165.0% | 164.9% | 165.7% | 167.3% | 158.9% | 158.7% | 157.5% | 152.4% | 140.3% | 113.2% |
| Share Change | — | -0.8pp | -14.9pp | +3.3pp | +1.4pp | +2.8pp | -6.0pp | +0.8pp | -0.4pp | +2.6pp | -9.4pp | -0.0pp | +0.7pp | +1.7pp | -8.4pp | -0.3pp | -1.1pp | -5.2pp | -12.1pp | -27.1pp |
Range$8.80B – $11.10B
CAGR+0.5%
Avg YoY Growth+4.1%
Median YoY Growth+5.6%
Accumulated Depreciation at Other Companies
Frequently Asked Questions
- What is Amgen's accumulated depreciation?
- Amgen (AMGN) reported accumulated depreciation of $9.30B in Q1 2026.
- How has Amgen's accumulated depreciation changed year-over-year?
- Amgen's accumulated depreciation decreased by 12.3% year-over-year, from $10.60B to $9.30B.
- What is the long-term trend for Amgen's accumulated depreciation?
- Over 5 years (2020 to 2025), Amgen's accumulated depreciation has grown at a 4.3% compound annual growth rate (CAGR), from $9.00B to $11.10B.